Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Precise objectives can improve student achievement in health education.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Antiandrogens don't help with COVID-19 and aren't recommended.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Trigonelline nanocrystal cream effectively promotes hair growth and may reduce side effects.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Plant-derived nanovesicles effectively deliver finasteride for hair regrowth in androgenetic alopecia.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

A special treatment speeds up chronic wound healing by fixing cell energy issues and reversing aging in cells.

Cinchonine Nanostructured Lipid Carriers serum safely and effectively stimulates hair growth and increases the number and size of hair follicles.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.